Health Care

Aarti Drugs Limited (AARTIDRUGS) Q4 FY23 Earnings Concall Transcript

● May 3, 2023

Aarti Drugs Limited (NSE:AARTIDRUGS) Q4 FY23 Earnings Concall dated May. 02, 2023. Corporate Participants: Adhish Patil — Chief Financial Officer Harshit M....

Glenmark Life Sciences Limited (GLS) Q4 FY23 Earnings Concall Transcript

● Apr 28, 2023

Glenmark Life Sciences Limited (NSE:GLS) Q4 FY23 Earnings Concall dated Apr. 28, 2023. Corporate Participants: Soumi Rao — General Manager, Corporate Communications...

Laurus Labs Limited Q4 FY23 Earnings Conference Call Insights

● Apr 28, 2023

Key highlights from Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Management Update: [00:09:24]LAURUSLABS said it invested in expanding non-ARV...

Laurus Labs Limited (LAURUSLABS) Q4 FY23 Earnings Concall Transcript

● Apr 28, 2023

Laurus Labs Limited (NSE:LAURUSLABS) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Satyanarayana Chava — Founder & Chief Executive Officer...

Dhampur Bio Organics Ltd (DBOL) Q4 FY23 Earnings Concall Transcript

● Apr 28, 2023

Dhampur Bio Organics Ltd (NSE:DBOL) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Mr. Navin Agrawal — Head of Institutional...

Syngene International Ltd (SYNGENE) Q4 FY23 Earnings Concall Transcript

● Apr 28, 2023

Syngene International Ltd (NSE:SYNGENE) Q4 FY23 Earnings Concall dated Apr. 27, 2023. Corporate Participants: Avantika Mishra — Investor Relations Jonathan Hunt — Managing Director...

Laurus Labs Limited Q4FY23 Earnings

● Apr 27, 2023

To meet the demands of the international pharmaceutical industry, Laurus Labs primarily provides a comprehensive and integrated portfolio of Active...

Syngene reported 21 percent rise in its Q4FY23 net profit

● Apr 26, 2023

Syngene reported Total revenue for Q4 FY23 of ₹994 Crore, up from ₹759 Crore year on year, a growth of...

Syngene International Q4FY23 results out, revenue rises by 31%

● Apr 26, 2023

Syngene (established in 1993) as a Biocon subsidiary is India’s first Contract Research Organization (CRO) which expanded later to be...

Nath Bio-Genes (India) Limited (NATHBIOGEN) Q4 FY23 Earnings Concall Transcript

● Apr 24, 2023

Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Q4 FY23 Earnings Concall dated Apr. 24, 2023. Corporate Participants: Unidentified Speaker — Devinder Khurana — Chief Financial...